Evidence map›Paper›PMID 34352008›Full record

ArticlePloS one2021

Development and implementation of the Ebola Exposure Window Calculator: A tool for Ebola virus disease outbreak field investigations.

Amy Whitesell, Nirma D Bustamante, Miles Stewart, Jeff Freeman, Amber M Dismer, Walter Alarcon, Aaron Kofman, Amen Ben Hamida, Stuart T Nichol, Inger Damon and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Amy WhitesellNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Nirma D BustamanteCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Miles StewartApplied Physics Laboratory, Johns Hopkins University, Baltimore, Maryland, United States of America.
Jeff FreemanApplied Physics Laboratory, Johns Hopkins University, Baltimore, Maryland, United States of America.
Amber M DismerCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Walter AlarconNational Institute of Occupational Safety and Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Aaron KofmanNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Amen Ben HamidaCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0003-1071-283X
Stuart T NicholNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Inger DamonNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Dana L HaberlingNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Mory KeitaWorld Health Organization, Geneva, Switzerland.ORCID 0000-0002-6304-9288
Gisèle MbuyiMinistry of Health, Kinshasa, Democratic Republic of Congo.
Gregory ArmstrongNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0002-9468-4970
Derek JuangDepartment of Medicine, University of California San Diego, San Diego, California, United States of America.
Jason DanaApplied Physics Laboratory, Johns Hopkins University, Baltimore, Maryland, United States of America.
Mary J ChoiNational Centers for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.ORCID 0000-0001-9373-2355

Funding

World Health Organization 001
6 · The paper itself

Abstract

During an Ebola virus disease (EVD) outbreak, calculating the exposure window of a confirmed case can assist field investigators in identifying the source of infection and establishing chains of transmission. However, field investigators often have difficulty calculating this window. We developed a bilingual (English/French), smartphone-based field application to assist field investigators in determining the exposure window of an EVD case. The calculator only requires the reported date of symptoms onset and the type of symptoms present at onset or the date of death. Prior to the release of this application, there was no similar electronic capability to enable consistent calculation of EVD exposure windows for field investigators. The Democratic Republic of the Congo Ministry of Health endorsed the application and incorporated it into trainings for field staff. Available for Apple and Android devices, the calculator continues to be downloaded even as the eastern DRC outbreak resolved. We rapidly developed and implemented a smartphone application to estimate the exposure window for EVD cases in an outbreak setting.

Indexed as

AlgorithmsSoftwareCell PhoneDemocratic Republic of the CongoDisease NotificationDisease OutbreaksEbolavirusHealth Plan ImplementationHemorrhagic Fever, EbolaHumansRisk Assessment

Identifiers

PMID34352008
PMCPMC8341611

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.